Nektar Therapeutics (NKTR) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-3.6
-2.39
-1.18
0.03

Details

Expected EPS
-3.027559
Actual EPS
-2.95
Surprise EPS
0.08
Surprise Percent
+2.56%

Description

Nektar Therapeutics (NKTR) has reported earnings of -2.95 per share for Q3 2025.

0 Comments

Share your thoughts